Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human IkB-alpha Antibody, R&D Systems™

Mouse Monoclonal Antibody has been used in 3 publications
Supplier: R&D Systems MAB4299SP
This item is not returnable.
View return policy
Description
IkB-alpha Monoclonal specifically detects IkB-alpha in Human samples. It is validated for Western Blot, Simple Western, Immunohistochemistry, Knockout Validated.Specifications
IkB-alpha | |
Monoclonal | |
LYOPH | |
Western Blot 0.1 ug/mL, Simple Western 1 ug/mL, Immunohistochemistry 5-25 ug/mL, Knockout Validated | |
P25963 | |
NFKBIA | |
E. coli-derived recombinant human IkB-alpha Met1-Leu317 Accession # P25963 | |
25 μg | |
Primary | |
Detects human IkB-alpha in Western blots. | |
Human | |
Purified |
Western Blot, Immunohistochemistry, KnockDown | |
417208 | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
alpha, I-kappa-B-alpha, IkappaBalphaNF-kappa-B inhibitor alpha, IKBAikB-alpha, IkBalpha, IkB-alpha, MAD3, MAD-3, Major histocompatibility complex enhancer-binding protein MAD3, NFKBI, NFKBIA, nuclear factor of kappa light chain gene enhancer in B-cells, nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor | |
Mouse | |
Protein A or G purified from hybridoma culture supernatant | |
RUO | |
4792 | |
Reconstitute at 0.5 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
IgG1 |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction